The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,774.50
Bid: 1,774.00
Ask: 1,774.50
Change: -3.50 (-0.20%)
Spread: 0.50 (0.028%)
Open: 1,780.00
High: 1,793.50
Low: 1,766.50
Prev. Close: 1,778.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Monday broker round-up UPDATE

Mon, 11th Mar 2013 07:23

Admiral Group: Berenberg ups target price from 1000p to 1060p, but still recommends selling.Amlin: Westhouse Securities raises target price from 440p to 455p, but downgrades from add to neutral.Anite Group: Invetsec downgrades from buy to hold with a target price of 157p.Aviva: Citigroup reduces target price from 479p to 432p reiterating its buy recommendation. Bank of America shifts target price from 330p to 350p, while its neutral rating is maintained.Avocet Mining: Investec cuts target price from 28.60p to 24p and keeps a hold recommendation.Babcock: JP Morgan ups target price from 1120p to 1230p, while maintaining an overweight rating.Bovis Homes: UBS increases target price from 560p to 700p retaining a neutral rating.BP: Deutsche Bank moves target price from 500p to 520p, while leaving its buy recommendation unaltered.British American Tabacco: Investec raises target price from 3350p to 3800p reiterating a buy recommendation.Capita: Westhouse Securities takes target price from 661p to 755p, while maintaining a sell recommendation.CAP-XX: Having had both its target price and recommendation under review, Cantor Fitzgerald rates a target price of 13p and a buy recommendation.Carillion: UBS lowers target price from 240p to 230p and reiterates a sell recommendation.Chime Communications: Investec ups target price from 265p to 300p and keeps a buy recommendation.Clinigen Group: Numis revises target price from 265p to 310p and stays with its buy recommendation.Cobham: Morgan Stanley ups target price from 175p to 195p and maintains an underweight rating. Exane BNP moves target price from 205p to 230p, while staying with its neutral rating.Daily Internet: Merchant Securities initiates with a target price of 8p and a buy recommendation.Dixons Retail: Deutsche Bank shifts target price from 31p to 36p keeping a buy recommendation.Escher Group: Panmure Gordon increases target price from 384p to 410p, while maintaining a buy recommendation.GlaxoSmithKline: Deutsche Bank increases target price from 1440p to 1530p and retains a hold recommendation. Espirito Santo shifts target price from 525p to 533p, while keeping a neutral rating.Hammerson: UBS moves target price from 525p to 560p, while leaving its buy recommendation unchanged.Herencia Resources: WH Ireland downgrades from buy to a speculative buy.HG Capital Trust: Oriel Securities revises target price from 1065p to 1130p and stays with its hold recommendation.Hiscox: Westhouse Securities ups target price from 525p to 533p reiterating a neutral rating.Howden Joinery: Numis raises target price from 245p to 260p keeping an add rating.HSBC Holdings: Exane BNP cuts target price from 850p to 825p and stays with its outperform rating.Hunting: Liberum Capital raises target price from 770p to 826p, while its hold recommendation is kept.ICAP: UBS reduces target price from 330p to 305p and downgrades from neutral to sell.IMI: UBS revises target price from 1000p to 1100p, but still recommends selling.Intu Properties: Espirito Santo reduces target price from 320p to 295p keeping a sell recommendation.Ladbrokers: Panmure Gordon raises target price from 195p to 219p, while maintaining a hold recommendation. Bank of America moves target price from 235p to 260p and retains its buy recommendation.Lloyds Banking Group: Bank of America shifts target price from 65p to 70p and retains its buy recommendation.Marshalls: Citigroup moves target price from 96p to 110p staying with its neutral rating.Perform: JP Morgan raises target price from 416p to 451p and keeps its neutral rating.Petro Matad: Westhouse Securities upgrades from add to buy with a target price of 15p.Playtech: Deutsche Bank takes target price from 550p to 650p and stays with its buy recommendation.Pure Water: WH Ireland shifts target price from 8.25p to 9.75p and maintains a buy recommendation.Reckitt Benckiser: Bank of America raises target price from 5000p to 5250p and reiterates its buy recommendation.Sage: Analysts at Bank of America-Merrill Lynch have downgraded their view to underperform. Bank of America shifts target price from 320p to 330p, while downgrading to underperform.Schroders: Credit Suisse ups target price from 1800p to 2150p keeping a neutral rating.Standard Chartered: Exane BNP revises target price from 1700p to 1750op leaving its neutral rating unchanged.Standard Life: Bank of America increases target price from 340p to 375p keeping an underperform rating.SThree: Numis downgrades to hold with a target price of 350p.St Ives: Numis moves target price from 132p to 150p reiterating its buy recommendation.St Modwen Properties: Numis revises target price from 259p to 280p and downgrades to add.Tullet Prebon: UBS shifts target price from 244p to 250p, while downgrading from neutral to sell.UBM: UBS ups target price from 700p to 740p and reiterates a neutral rating. Citigroup moves target price from 734p to 749p, while its neutral rating is kept.William Hill: Bank of America takes target price from 315p to 420p and leaves its underperform rating unaltered.Wolseley: UBS raises target price from 2800p to 3375p and keeps a neutral rating.
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.